Free CME from PeerView


Dermatology CME

Credits: 0.5 CME / MOC
Penn State College of Medicine
Targeting Disease Pathophysiology to Achieve Effective Treatment in Prurigo Nodularis
May 08, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Harnessing the Power of Immunotherapy in Resectable Melanoma: Guidance for Delivering Effective Adjuvant and Neoadjuvant Strategies
March 22, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Moving Beyond Off-Label Management in Prurigo Nodularis: Exploring New Treatment Options
March 21, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Understanding TYK2’s Role in Psoriasis Pathogenesis and Taking a Practical Approach to Realizing Its Potential in the Clinic
January 27, 2023
Credits: 0.5 CME / NCPD / IPCE
PVI, PeerView Institute for Medical Education
Taking a Team-Based Approach to Moderate to Severe Psoriasis in an Era of Expanding Oral Treatment Options: Advanced Practice Clinicians as Key Partners in Care
December 20, 2022
Credits: 0.5 CME
Penn State College of Medicine
Hope on the Horizon for Hidradenitis Suppurativa: Leveraging Emerging Biologics to Improve Quality of Life
December 06, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Using Biologics to Manage Moderate to Severe Atopic Dermatitis: Compare Your Approach With Experts From Around the World
September 27, 2022
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Taking a New Look at Prurigo Nodularis: How Is Emerging Evidence Regarding Disease Pathophysiology and Treatment Influencing Patient Care?
September 01, 2022
Credits: 1.0 CME / MOC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Can Team-Based Care and Novel Therapies Improve Outcomes in Moderate to Severe Pediatric Atopic Dermatitis?
August 18, 2022
Credits: 1.0 CME / MOC / NCPD / ILNA
PVI, PeerView Institute for Medical Education
Uncovering Gene Fusions & Other Key Genomic Alterations in Lung, Thyroid, Colon, Breast, and Other Solid Tumors to Enable All Patients to Gain the Full Benefits of Targeted Treatment
August 16, 2022
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
New Directions in Kinase Inhibition in Systemic Lupus Erythematosus: Emerging Evidence From Copenhagen
July 19, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
The Power of Team-Based Care and Novel Therapies in Alopecia Areata and Atopic Dermatitis: What Advanced Care Providers Need to Know
June 17, 2022
PVI, PeerView Institute for Medical Education
Immunotherapy Has Arrived in Advanced BCC: Collaborative Strategies for Making the Most of Novel Immune-Based Treatment
June 06, 2022
PVI, PeerView Institute for Medical Education
Fine-Tuning the JAK/STAT Pathway in Psoriasis: Safely Targeting the Underlying Mechanisms of Disease With TYK2 Inhibition
May 25, 2022
PVI, PeerView Institute for Medical Education
Addressing the Burden of Prurigo Nodularis: Expert Insight on Disease Pathogenesis and the Clinical Potential of Novel Therapeutic Options
April 28, 2022
PVI, PeerView Institute for Medical Education
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvant Immunotherapy to Facilitate Progress in Early-Stage Cancers
April 10, 2022
PVI, PeerView Institute for Medical Education
Expert Insights From Around the Globe on Tailoring Treatment for Patients With Atopic Dermatitis
November 03, 2021
PVI, PeerView Institute for Medical Education
Changing the Game for Patients With Prurigo Nodularis: Best Practices to Achieve Treatment Goals and Improve Quality of Life
October 29, 2021
Medical Learning Institute, Inc.
Test Your Knowledge of New and Emerging Therapies for Moderate to Severe Atopic Dermatitis: Latest Evidence and Clinical Potential
September 17, 2021
Medical Learning Institute, Inc.
Translating Science to Transform Clinical Practice: How MEK Inhibitors Are Changing the Treatment Landscape of NF1 and NF1-Associated Tumors
July 15, 2021
Medical Learning Institute, Inc.
Building Better Models for Melanoma Care: Continued Progress With Immunotherapy in Resectable and Unresectable Disease
July 07, 2021

Pages